IL78937A - Pharmaceutical compositions containing tissue-plasminogen activator - Google Patents

Pharmaceutical compositions containing tissue-plasminogen activator

Info

Publication number
IL78937A
IL78937A IL78937A IL7893786A IL78937A IL 78937 A IL78937 A IL 78937A IL 78937 A IL78937 A IL 78937A IL 7893786 A IL7893786 A IL 7893786A IL 78937 A IL78937 A IL 78937A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
plasminogen activator
containing tissue
tissue
Prior art date
Application number
IL78937A
Other languages
English (en)
Other versions
IL78937A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858513358A external-priority patent/GB8513358D0/en
Priority claimed from GB858521704A external-priority patent/GB8521704D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL78937A0 publication Critical patent/IL78937A0/xx
Publication of IL78937A publication Critical patent/IL78937A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
IL78937A 1985-05-28 1986-05-27 Pharmaceutical compositions containing tissue-plasminogen activator IL78937A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858513358A GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation
GB858521704A GB8521704D0 (en) 1985-08-31 1985-08-31 Formulation

Publications (2)

Publication Number Publication Date
IL78937A0 IL78937A0 (en) 1986-09-30
IL78937A true IL78937A (en) 1990-11-29

Family

ID=26289289

Family Applications (1)

Application Number Title Priority Date Filing Date
IL78937A IL78937A (en) 1985-05-28 1986-05-27 Pharmaceutical compositions containing tissue-plasminogen activator

Country Status (22)

Country Link
US (1) US5112609A (it)
AT (1) AT391812B (it)
AU (1) AU569429B2 (it)
BE (1) BE904831A (it)
CA (1) CA1297008C (it)
CH (1) CH664495A5 (it)
DE (1) DE3617753A1 (it)
DK (1) DK163174C (it)
ES (1) ES8706443A1 (it)
FI (1) FI85334C (it)
FR (1) FR2593393B1 (it)
GB (1) GB2176703B (it)
GR (1) GR861365B (it)
HU (1) HU200695B (it)
IL (1) IL78937A (it)
IT (1) IT1191925B (it)
LU (1) LU86445A1 (it)
NL (1) NL8601354A (it)
NO (1) NO171344C (it)
NZ (1) NZ216306A (it)
PT (1) PT82647B (it)
SE (1) SE462893B (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX197183A (es) * 1982-05-05 1994-02-28 Genentech Inc Activador de plasminogeno de tejido humano
US5185259A (en) * 1982-05-05 1993-02-09 Genentech, Inc. Truncated human tissue plasminogen activator
FI831484L (fi) 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
HUT41632A (en) * 1985-03-06 1987-05-28 Survival Technology Process for preparing agents for the enhancement of protein absorption
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
US5034225A (en) * 1985-12-17 1991-07-23 Genentech Inc. Stabilized human tissue plasminogen activator compositions
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
NL8701113A (nl) * 1986-05-12 1987-12-01 Wellcome Found Nieuwe farmaceutische toepassing.
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8814604D0 (en) * 1988-06-20 1988-07-27 Wellcome Found Medicaments
WO1990001334A1 (en) * 1988-08-05 1990-02-22 Codon Formulations for plasminogen activator using aspartate
GB8819607D0 (en) * 1988-08-17 1988-09-21 Wellcome Found Novel combination
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
GB9000629D0 (en) * 1990-01-11 1990-03-14 Porton Prod Ltd Tissue plasminogen activator
AU664469B2 (en) * 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
DK0827751T3 (da) * 1996-09-06 2003-03-31 Chemo Sero Therapeut Res Inst Medicinsk præparat indeholdende vævsplasminogenaktivator og nicotinamid
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6355243B1 (en) † 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US20030077682A1 (en) * 2001-09-07 2003-04-24 Hung Paul Porwen Human tissue urokinase type plasminogen activator formulation
US8617863B2 (en) * 2008-06-04 2013-12-31 Grifols Therapeutics Inc. Composition, method, and kit for preparing plasmin
PT2403865E (pt) 2009-03-03 2015-11-18 Grifols Therapeutics Inc Métodos de preparação de plasminogénio

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
FR2252842B1 (it) * 1973-12-03 1977-11-04 Fabre Sa Pierre
DE3015699C2 (de) * 1979-04-26 1982-07-15 Asahi Kasei Kogyo K.K., Osaka Herstellung eines Plasminogen-Aktivators
CA1154671A (fr) * 1979-07-27 1983-10-04 Lucien D. D'hinterland Separation d'un activateur tissulaire du plasminogene
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
WO1984001714A1 (en) * 1982-10-29 1984-05-10 Mitsui Toatsu Chemicals Novel plasminogen activator, process for its preparation, and thrombolytic drug containing the same
DE3382389D1 (de) * 1982-12-14 1991-10-02 South African Inventions Plasminogenaktivator.
AU554862B2 (en) * 1982-12-14 1986-09-04 Implico B.V. Plasminogen activator isolated by affinity chromatography
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
DE3439980A1 (de) * 1984-11-02 1986-05-07 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung sowie pasteurisierung von urokinase
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
EP0417662B1 (de) * 1989-09-13 1995-12-13 Maschinenfabrik Rieter Ag Verfahren zum Starten eines Arbeitsablaufs eines Bedienungsautomaten an einer Textilmaschine

Also Published As

Publication number Publication date
DE3617753A1 (de) 1986-12-04
AU569429B2 (en) 1988-01-28
SE8602404L (sv) 1986-11-29
GR861365B (en) 1986-09-29
PT82647A (en) 1986-06-01
IL78937A0 (en) 1986-09-30
FI862226A (fi) 1986-11-29
NO171344C (no) 1993-03-03
FI862226A0 (fi) 1986-05-27
PT82647B (pt) 1989-01-30
IT8648064A0 (it) 1986-05-27
GB2176703B (en) 1988-12-07
BE904831A (fr) 1986-11-27
SE8602404D0 (sv) 1986-05-27
AU5796586A (en) 1986-12-04
DK246886D0 (da) 1986-05-27
IT1191925B (it) 1988-03-31
FR2593393A1 (fr) 1987-07-31
HUT42330A (en) 1987-07-28
FR2593393B1 (fr) 1989-06-02
ATA141186A (de) 1990-06-15
NZ216306A (en) 1989-10-27
GB8612781D0 (en) 1986-07-02
ES555352A0 (es) 1987-07-01
DK163174C (da) 1992-06-22
FI85334C (fi) 1992-04-10
CH664495A5 (de) 1988-03-15
NL8601354A (nl) 1986-12-16
HU200695B (en) 1990-08-28
NO171344B (no) 1992-11-23
SE462893B (sv) 1990-09-17
AT391812B (de) 1990-12-10
CA1297008C (en) 1992-03-10
FI85334B (fi) 1991-12-31
US5112609A (en) 1992-05-12
GB2176703A (en) 1987-01-07
ES8706443A1 (es) 1987-07-01
DK246886A (da) 1986-11-29
DK163174B (da) 1992-02-03
DE3617753C2 (it) 1988-06-30
LU86445A1 (fr) 1986-12-05
NO862095L (no) 1986-12-01

Similar Documents

Publication Publication Date Title
IL78937A0 (en) Pharmaceutical compositions containing tissue-plasminogen activator
PH22480A (en) New sulphonylaminoethyl compounds and pharmaceutical compositions containing these compounds
IL74758A0 (en) Acyltripeptides and pharmaceutical compositions containing them
ZA864602B (en) 2-arylimidazoles and pharmaceutical compositions containing these compounds
IL82221A0 (en) Phenyl-piperazines and pharmaceutical compositions containing them
IL78739A (en) Ascorbic acid derivatives and pharmaceutical compositions containing them
GB2174904B (en) Vasculoprotecting pharmaceutical compositions
NZ216307A (en) Pharmaceutical compositions containing tissue plasminogen activator
IL74865A0 (en) 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
IL77138A0 (en) Pharmaceutical compositions containing 1-heteroaryl-4-arylpyrazolin-5-ones
IL79376A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
ZA859731B (en) Pharmaceutical compositions containing tetrahydrobenzthiazoles
GB2171600B (en) Pharmaceutical compositions
IL76188A (en) 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them
IL80232A0 (en) N-substituted diphenylpiperidines,their manufacture and pharmaceutical compositions containing them
GB8517958D0 (en) Compositions containing melatonin/homologues
EP0197752A3 (en) Pharmaceutical compositions
IL86711A0 (en) 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them
NZ225466A (en) 1-aminoalkyl-1h-indole derivatives and pharmaceutical compositions containing certain derivatives thereof
GB2167414B (en) Flavolignan derivatives and pharmaceutical compositions containing them
IL79980A0 (en) Pharmaceutical composition containing ypsilon-interferon
IL79003A0 (en) Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them
EP0191735A3 (en) Novel oxaluric acid derivatives and pharmaceutical compositions containing them
IL78642A0 (en) Dihydropyridines and pharmaceutical compositions containing them
IL74667A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RH Patent void